ArticleBreast cancer research : BCR2019

Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.

Marie-Julie Nokin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.